0 likes | 23 Views
The global Antibiotics Market size is predicted to reach $64.79 billion with a CAGR of 4.1% by 2030.
E N D
Antibiotics Market The global Antibiotics Market size is predicted to reach $64.79 billion with a CAGR of 4.1% by 2030 • Next Move Strategy Consulting
Agenda Market Overview Market Segmentation Regional Analysis Key Players Key Takeaways • Next Move Strategy Consulting
Market Overview • Antibiotic is an antimicrobial substance, which combats viral infections and occasionally protozoan infections. • They are used to cure several diseases such as strep throat, sinus infections, pneumonia, skin infections, and others. • Antibiotics are the most important type of antibacterial agent for fighting bacterial infections and prevention of such infection. • These may either kill or inhibit the growth of bacteria in the human body. These drugs are also used in surgical procedures to help in preventing infection of incisions. • Antibiotics are also used to prevent infection in cases of neutropenia particularly cancer-related. • Next Move Strategy Consulting
Market Segmentation By Drug Origin By Spectrum of Activity • Synthetic Natural • Semisynthetic • Narrow-spectrum Antibiotic • Broad-spectrum Antibiotic By Route of Administration By Product • Intravenous • Oral • Others • Penicillins • Sulfonamides • Fluroquinilones • Macrolides • Carbapenems • Cephalosporins • Aminoglycosides • Other Product Types By Class • Quinolones • Macrolides • Beta Lactam & Beta Lactamase • Others • Next Move Strategy Consulting
Regional Analysis North America Europe Asia-Pacific RoW • The U.S. • Canada • Mexico • The UK • Germany • France • Italy • Russia • Rest of Europe • China • Japan • India • South Korea • Australia • Rest of Asia Pacific • Latin America • Middle East • Africa • Next Move Strategy Consulting
Key Players • Wockhardt • Shionogi • Abbott Laboratories • Allergan Plc • F.Hoffmann-La Roche Ltd. • GlaxoSmithKline Plc • Mylan N.V. • Novartis International AG (Sandoz) • Sun Pharmaceutical • Teva Pharmaceutical • Next Move Strategy Consulting
Key Takeaways • Rising Incidence of Infectious Diseases: Increasing prevalence of bacterial infections, including those resistant to existing treatments, fuels demand for new and effective antibiotics. • Antibiotic Resistance: The growing problem of antibiotic resistance drives the need for the development of new antibiotics that can overcome resistant strains. • Advancements in Biotechnology: Innovations in biotechnology and drug discovery are leading to the development of novel antibiotics with improved efficacy and safety profiles. • Expanding Healthcare Infrastructure: Growth in healthcare infrastructure and access to medical services in developing regions supports market expansion. • Next Move Strategy Consulting
Thank You Next Move Strategy Consulting • +1-217-650-7991 • info@nextmsc.com • https://www.nextmsc.com/ Follow Us Access Full Report: https://www.nextmsc.com/report/antibiotics-market • Next Move Strategy Consulting